comparemela.com

Page 2 - Duncan Cancer Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Approval in Early Breast Cancer: First Advance in 20 Years

The CDK4/6 inhibitor abemaciclib (Verzenio) has been approved for use in early breast cancer for certain patients who are at high risk for recurrence.

Baylor receives more than $20 million in CPRIT funding

Baylor receives more than $20 million in CPRIT funding
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Student Spotlight: Victor Albornoz-Alvarez

Content As a young medical student, Victor was relentless in his quest to save Hugo from Osteosarcoma, the most common primary bone tumor in adolescents and young adults. Victor s fight to save his brother has motivated him to become an expert in head and neck cancers and to work toward curing the disease that took his brother s life.  “Most of what I do is networking to find out what ways I can help the field,” Victor said. In addition to leading the Baylor Students Against Cancer Group, he networks with cancer experts across the Texas Medical Center to see how he can bring more opportunities to students interested in pursuing careers in cancer research and care. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.